Thursday, April 2, 2020

Pharmacology Preconference

The Science and Clinical Application of Cannabinoids

  1. Define the endocannabinoid system
  2. Discuss the evidence and clinical uses for cannabinoids.
  3. Review practical clinical basics and safety considerations for cannabinoids.

Pharmacologic Management of Depression in Adults

  1. Review the common classes of antidepressant medications and their effectiveness in treating depression
  2. Discuss the dosing, titration, contraindications and adverse effects of common anti-depressant therapies
  3. Explain the application of antidepressant therapies in special populations including older adults, pregnant women, and patients with cardiovascular diseases including arrhythmia and heart failure

Clinical Management of Thyroid Disorder

  1. Define hypothyroidism and hyperthyroidism and list common causes
  2. Discuss oral thyroid replacement products available for the treatment of hypothyroidism and the appropriate use of these products
  3. Compare the available treatment modalities for the patient with hyperthyroidism and their appropriate use
  4. Describe appropriate management strategies for special populations with thyroid disorders including older patients, pregnant women and those with cardiovascular diseases

Pharmacologic Management of Patients with Complex Co-Morbidities: Preventing the Progression of CKD

  1. Review the interaction between the cardiovascular and renal systems and the implications this has on selection of pharmacotherapeutic treatments
  2. Discuss the evidence for specific medications that slow progression and reduce cardiovascular risk in patients with CKD
  3. Discuss medical management of blood pressure, blood glucose and heart failure in patients with CKD

General Sessions

Advancing Global Health through Nursing Leadership

  1. Review the demographic disparities that impact optimal healthcare throughout the world
  2. Describe interventions that reshape and transform health care systems
  3. Highlight the role that nurse’s and nursing leadership can play to improve the health of individuals and populations and close the gap in health disparity

Current Trends in the Diagnosis and Management of Ischemic Heart Disease and Microvascular Angina

  1. Review current National guideline recommendations for the management of stable ischemic heart disease
  2. Describe microvascular angina and how its diagnosis and treatment differs from that of coronary artery disease
  3. Explain the role of Coronary CT in risk assessment, diagnosis, and treatment of preclinical atherosclerosis and microvascular disease”

Friday, April 3, 2020

From Patient Identification to Patient Communications: Improving Outcomes With Nonstatin LDL-C Lowering Therapy

  1. Identify patients for potential benefit with the use of nonstatin, LDL-C-lowering therapies
  2. Interpret data with PCSK9 inhibitors and ezetimibe in patients with very high-risk ASCVD and severe hypercholesterolemia
  3. Indicate key messages to disseminate to patients with elevated LDL-C to reduce their ASCVD risk

Sex Differences in Prevention and Management of Heart Failure

  1. Describe the prevalence of heart failure among women and how this compares to men
  2. Highlight the sex differences in the use and response to evidence-based pharmacological, device and advanced HF therapies
  3. Explore emerging areas of research in sex differences in the treatment of HF”

Optimal Nutrition for Cardiovascular Risk Reduction: What should we eat now?

  1. Review current National guideline recommendations regarding diet for CVD prevention and management
  2. Discuss current diet trends and their CV risks and benefits, including ketogenic, paleo and intermittent fasting diets
  3. Describe practical strategies for effective nutritional counseling in clinical cardiovascular clinical settings including the hospital, clinic and cardiac rehabilitation centers

Inflammation and Cardiovascular Disease: Understanding the Relationship

  1. Explain the relationship between inflammation, atherosclerosis, and established CVD risk factors
  2. Describe the association between chronic inflammatory disorders and CVD
  3. Review the potential therapeutic targets in the treatment of vascular inflammation: current and future research

Cryptogenic Stroke and TIA: The importance of early detection and treatment of Atrial Fibrillation

  1. Define cryptogenic stroke, TIA and their prevalence
  2. Describe how stroke and TIA are diagnosed and differentiated in clinical practice
  3. Explain the relationship between atrial fibrillation, stroke, and TIA
  4. List several key strategies, including pharmacotherapy, to prevent stroke and recurrent cerebrovascular events

Skill Build Part 1: Interpreting and Applying the 12 lead ECG in Clinical Settings

  1. Review the major components of the 12-lead ECG including the axis, p-wave, QRS complex, T wave, ST-segment, and QT duration.
  2. Outline a systematic approach to 12-lead ECG interpretation and application to patient care
  3. Differentiate VT vs SVT and aberrancy
  4. List the criteria LVH, fascicular and bundle branch blocks, and acute/remote myocardial infarction

Breakout: Behavior Change Principles in Action: Helping patients set goals and follow a heart-healthy eating plan

  1. Discuss lifestyle behavior change principles and their application to setting goals and following a heart-healthy diet
  2. Summarize practical dietary assessment and counseling strategies that the CV nurse can apply in clinical settings
  3. Demonstrate communication techniques to improve diet adherence, prevent relapse and build confidence in making a successful dietary change.

Breakout: Trends and Effects of Vaping, Energy Drinks and Binge Drinking on Health and Well-Being

  1. Review current U.S. trends regarding vaping, energy drinks and binge drinking
  2. Discuss the general and CV risks associated with vaping, energy drinks and binge drinking
  3. Describe strategies for counseling patients regarding the use of e-cigarettes or other vaping products, energy drinks and alcohol use

Skill Build Part 2: Heart Sounds: what is your patient’s heart telling you?

  1. Review basic heart sounds (S1, S2) and recognize third, fourth sounds, gallops and pericardial rubs
  2. Describe and identify diagnostic heart sounds/murmurs including hypertrophic cardiomyopathy, mitral valve prolapse, and aortic and mitral stenosis and regurgitation.
  3. Discuss the clinical significance of pathological heart sounds and identify next steps in clinical management

Saturday, April 4, 2020

Challenge of Cardiovascular Risk Reduction in Racial and Ethnic Minorities

  1. Describe the healthcare disparities in risk factor prevalence, disease states and CVD outcomes in the United States
  2. Explain the genomic variation and the impact of the environment on CVD
  3. Review successful strategies to close the gap in healthcare disparities among racial and ethnic minorities

Pharmacogenomics, Precision Health, and the Management of Cardiovascular Diseases

  1. Define pharmacogenomics and how it relates to personalized or precision health
  2. Describe the application of pharmacogenomics and implementation of precision health in the management of CV risk factors and diseases

Innovations in Cardiac Rehabilitation: New delivery models including home-based programs

  1. Review current guideline-based recommendations for cardiac rehab
  2. Describe enrollment rates and barriers to cardiac rehab participation
  3. Discuss alternative models to traditional in-center cardiac rehab and associated outcomes

Fearless Soul: The Call to Nursing and the Courage to Stay

  1. Identify sources of personal accomplishment in your work
  2. Summarize ways to use your authentic voice within the shifting paradigm of healthcare
  3. Discuss how employing the wisdom of your original calling improves patient outcomes in the current healthcare environment.

Accreditation Statement

This educational activity is provided by the Preventive Cardiovascular Nurses Association (PCNA). Multiple educational grants have been requested to support this program. PCNA is approved as a provider of nurse practitioner continuing education (CE) programs by the American Association of Nurse Practitioners (AANP), provider number 030602. This program was planned in accordance with AANP CE Policies and Commercial Support Standards.